Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

European stocks open sharply higher on ECB stimulus; Dax up 2.11%

Published 03/11/2016, 03:27 AM
Updated 03/11/2016, 03:27 AM
© Reuters.  European stocks rally on ECB policy move, financials lead

Investing.com - European stocks opened sharply higher on Friday, after the European Central Bank announced a much larger than expected stimulus package on Thursday, although ECB President Mario Draghi said the bank does not intend to cut rates further.

During European morning trade, the EURO STOXX 50 jumped 2.06%, France’s CAC 40 rallied 2.24%, while Germany’s DAX 30 surged 2.11%.

European stocks rallied after the ECB cut interest rates across the euro zone to new record lows and boosted its quantitative easing program on Thursday.

The ECB wrong footed markets by cutting its benchmark interest rate to a record-low of zero from 0.05%. Market watchers had been expecting no change.

The central bank also cut the deposit facility rate deeper into negative territory, to minus 0.4% and cut the marginal lending rate cut to 0.25% from 0.30%.

In addition, the ECB boosted its quantitative easing program by €20 billion per month to €80 billion, starting in April.

European equities lost some ground however after Draghi said that the ECB did not anticipate that it will be necessary to reduce interest rates further, but added that this could change.

Financial stocks were sharply higher, as French lenders Societe Generale (PA:SOGN) and BNP Paribas (PA:BNPP) surged 3.74% and 4.67%, while Germany’s Deutsche Bank (DE:DBKGn) and Commerzbank (DE:CBKG) rallied 3.30% and 3.46%.

Among peripheral lenders, Italy’s Unicredit (MI:CRDI) and Intesa Sanpaolo (MI:ISP) soared 5.30% and 4.38% respectively, while Spanish banks BBVA (MC:BBVA) and Banco Santander (MC:SAN) jumped 2.58% and 3.13%.

Elsewhere, Sanofi (PA:SASY) SA rallied 1.61% after saying that its and U.S. company Regeneron Pharmaceuticals Inc (NASDAQ:REGN).’s experimental rheumatoid arthritis therapy helped patients more than AbbVie Inc (NYSE:ABBV).’s Humira in a late-stage trial.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

In London, FTSE 100 jumped 1.50%, as U.K. lenders tracked their European counterparts sharply higher.

Shares in HSBC Holdings (LON:HSBA) gained 1.31% and Lloyds Banking (LON:LLOY) rallied 2.35%, while the Royal Bank of Scotland (LON:RBS) and Barclays (LON:BARC) surged 2.75% and 3.38% respectively.

Mining stocks were also broadly higher on the commodity-heavy index. Anglo American (LON:AAL) advanced 1.21% and Bhp Billiton (LON:BLT) gained 1.99%, while Rio Tinto (LON:RIO) and Glencore (LON:GLEN) climbed 2.30% and 2.66% respectively.

Meanwhile, Aviva (LON:AV) Plc remained one of the top performers on the index for a second consecutive session, with shares up 4.23% after the U.K. insurer reported on Thursday a Solvency II ratio of 180%, disclosing its capital strength under new European Union rules for the first time, and raised its dividend by 15%.

In the U.S., equity markets pointed to a higher open. The Dow Jones Industrial Average futures pointed to a 0.88% gain, S&P 500 futures a 1.02% jump, while the Nasdaq 100 futures indicated a 1.26% rally.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.